{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:02:06Z","timestamp":1787068926743,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"crossref","award":["4031206"],"award-info":[{"award-number":["4031206"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-025-00991-3","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:38:04Z","timestamp":1767631084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the neuroprotective effects of alpha lipoic acid-loaded folate-conjugated chitosan nanoparticles against 6-OHDA-induced apoptosis and oxidative stress in an in vitro Parkinson\u2019s disease model"],"prefix":"10.1186","volume":"27","author":[{"given":"Elaheh","family":"Gheybi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jalili\u2011Nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Mozhdeh","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"AlAlikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Soukhtanloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"991_CR1","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan W-L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Exon; 2018. pp. 3\u201326.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"10291","key":"991_CR2","first-page":"2284","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s Disease Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Parkinson\u2019s Disease Lancet"},{"issue":"S1","key":"991_CR3","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/ana.410320703","volume":"32","author":"C Olanow","year":"1992","unstructured":"Olanow C. An introduction to the free radical hypothesis in parkinson\u2019s disease. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 1992;32(S1):S2\u20139.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"key":"991_CR4","doi-asserted-by":"crossref","unstructured":"Pardo-Moreno T, Garc\u00eda-Morales V, Suleiman-Martos S, Rivas-Dom\u00ednguez A, Mohamed-Mohamed H, Ramos-Rodr\u00edguez JJ, Melguizo-Rodr\u00edguez L, Gonz\u00e1lez-Acedo A. Current treatments and new, tentative therapies for Parkinson\u2019s disease. Pharmaceutics. 2023;15(3):770.","DOI":"10.3390\/pharmaceutics15030770"},{"issue":"5","key":"991_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","volume":"19","author":"RM de Bie","year":"2020","unstructured":"de Bie RM, et al. Initiation of Pharmacological therapy in parkinson\u2019s disease: when, why, and how. Lancet Neurol. 2020;19(5):452\u201361.","journal-title":"Lancet Neurol"},{"issue":"6","key":"991_CR6","doi-asserted-by":"publisher","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","volume":"2","author":"J Massano","year":"2012","unstructured":"Massano J, Bhatia KP. Clinical approach to parkinson\u2019s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med. 2012;2(6):a008870.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"991_CR7","unstructured":"Available from: https:\/\/lpi.oregonstate.edu\/mic\/dietary-factors\/lipoic-acid"},{"issue":"1","key":"991_CR8","first-page":"313021","volume":"2015","author":"B Skibska","year":"2015","unstructured":"Skibska B, Goraca A. The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress. Oxidative Med Cell Longev. 2015;2015(1):313021.","journal-title":"Oxidative Med Cell Longev"},{"key":"991_CR9","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.nxnano.2024.100129","volume":"7","author":"F Kurul","year":"2025","unstructured":"Kurul F, et al. Nanomedicine: how nanomaterials are transforming drug delivery, bio-imaging, and diagnosis. Next Nanatechnol. 2025;7:100129.","journal-title":"Next Nanatechnol"},{"issue":"4","key":"991_CR10","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1080\/87559129.2021.1950176","volume":"39","author":"A Singh","year":"2023","unstructured":"Singh A, Mittal A, Benjakul S. Chitosan, chitooligosaccharides and their polyphenol conjugates: preparation, bioactivities, functionalities and applications in food systems. Food Reviews Int. 2023;39(4):2297\u2013319.","journal-title":"Food Reviews Int"},{"issue":"1","key":"991_CR11","doi-asserted-by":"publisher","first-page":"e10254","DOI":"10.1002\/btm2.10254","volume":"7","author":"M Bagheri","year":"2022","unstructured":"Bagheri M, et al. Chitosan nanofiber biocomposites for potential wound healing applications: antioxidant activity with synergic antibacterial effect. Bioeng Translational Med. 2022;7(1):e10254.","journal-title":"Bioeng Translational Med"},{"issue":"7","key":"991_CR12","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/plants10071365","volume":"10","author":"F Quitadamo","year":"2021","unstructured":"Quitadamo F, et al. Chitosan-induced activation of the antioxidant defense system counteracts the adverse effects of salinity in durum wheat. Plants. 2021;10(7):1365.","journal-title":"Plants"},{"issue":"6","key":"991_CR13","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/acsomega.0c05500","volume":"6","author":"E McCord","year":"2021","unstructured":"McCord E, et al. Folate receptors\u2019 expression in gliomas May possess potential nanoparticle-based drug delivery opportunities. ACS Omega. 2021;6(6):4111\u20138.","journal-title":"ACS Omega"},{"key":"991_CR14","doi-asserted-by":"publisher","first-page":"106025","DOI":"10.1016\/j.jddst.2024.106025","volume":"100","author":"O Y\u00fccel","year":"2024","unstructured":"Y\u00fccel O, et al. Folate receptor-targeted indomethacin-loaded gold nanoparticles enhance drug chemotherapeutic efficacy in glioblastoma cells and spheroids. J Drug Deliv Sci Technol. 2024;100:106025.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"35","key":"991_CR15","doi-asserted-by":"publisher","first-page":"355101","DOI":"10.1088\/1361-6528\/ab9395","volume":"31","author":"O Yucel","year":"2020","unstructured":"Yucel O, et al. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized Trojans for drug delivery to folate receptor-positive cancer cells. Nanotechnology. 2020;31(35):355101.","journal-title":"Nanotechnology"},{"issue":"4","key":"991_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/15376516.2016.1275908","volume":"27","author":"\u00c1 Rodr\u00edguez-Huam\u00e1n","year":"2017","unstructured":"Rodr\u00edguez-Huam\u00e1n \u00c1, et al. Antioxidant and neuroprotector effect of lepidium meyenii (maca) methanol leaf extract against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cells. Toxicol Mech Methods. 2017;27(4):279\u201385.","journal-title":"Toxicol Mech Methods"},{"key":"991_CR17","first-page":"108893","volume-title":"Naringenin alleviates 6-hydroxydopamine induced parkinsonism in SHSY5Y cells and zebrafish model","author":"S Kesh","year":"2021","unstructured":"Kesh S, Kannan RR, Balakrishnan A. Naringenin alleviates 6-hydroxydopamine induced parkinsonism in SHSY5Y cells and zebrafish model. Volume 239. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology; 2021. p. 108893."},{"key":"991_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol. 2013;1078:9\u201321.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"991_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ. The SH-SY5Y cell line in parkinson\u2019s disease research: a systematic review. Mol Neurodegener. 2017;12(1):10.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"991_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/1061186X.2019.1710839","volume":"28","author":"S Dehghani","year":"2020","unstructured":"Dehghani S, et al. Multifunctional MIL-Cur@FC as a theranostic agent for magnetic resonance imaging and targeting drug delivery: in vitro and in vivo study. J Drug Target. 2020;28(6):668\u201380.","journal-title":"J Drug Target"},{"issue":"1","key":"991_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12951-022-01380-2","volume":"20","author":"A Kefayat","year":"2022","unstructured":"Kefayat A, et al. Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded\/folic acid-targeted Chitosan nanoparticles for murine triple-negative breast cancer treatment. J Nanobiotechnol. 2022;20(1):169.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"991_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.colsurfb.2010.08.045","volume":"82","author":"J Liang","year":"2011","unstructured":"Liang J, et al. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles. Colloids Surf B Biointerfaces. 2011;82(2):297\u2013301.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"991_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371.","journal-title":"AAPS J"},{"issue":"3","key":"991_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1208\/s12248-019-0297-y","volume":"21","author":"N Zaborenko","year":"2019","unstructured":"Zaborenko N, et al. First-Principles and empirical approaches to predicting in vitro dissolution for pharmaceutical formulation and process development and for product release testing. AAPS J. 2019;21(3):32.","journal-title":"AAPS J"},{"key":"991_CR25","doi-asserted-by":"crossref","unstructured":"Muselik J et al. A critical overview of FDA and EMA statistical methods to compare in vitro drug dissolution profiles of pharmaceutical products. Pharmaceutics, 2021. 13(10).","DOI":"10.3390\/pharmaceutics13101703"},{"issue":"5","key":"991_CR26","doi-asserted-by":"publisher","first-page":"119221","DOI":"10.1016\/j.bbamcr.2022.119221","volume":"1869","author":"S Ebrahimi","year":"2022","unstructured":"Ebrahimi S, et al. SP\/NK1R system regulates carcinogenesis in prostate cancer: shedding light on the antitumoral function of aprepitant. Biochim Biophys Acta Mol Cell Res. 2022;1869(5):119221.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"991_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/biof.1953","volume":"49","author":"S Ebrahimi","year":"2023","unstructured":"Ebrahimi S, et al. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma. BioFactors. 2023;49(4):900\u201311.","journal-title":"BioFactors"},{"issue":"1","key":"991_CR28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/19476337.2018.1491625","volume":"16","author":"B Liu","year":"2018","unstructured":"Liu B, et al. Synthesis, characterization of catechin-loaded folate-conjugated Chitosan nanoparticles and their anti-proliferative effect. CyTA - J Food. 2018;16(1):868\u201376.","journal-title":"CyTA - J Food"},{"issue":"1","key":"991_CR29","doi-asserted-by":"publisher","first-page":"372725","DOI":"10.1155\/2012\/372725","volume":"2012","author":"H Katas","year":"2012","unstructured":"Katas H, Hussain Z, Ling TC. Chitosan nanoparticles as a percutaneous drug delivery system for hydrocortisone. J Nanomaterials. 2012;2012(1):372725.","journal-title":"J Nanomaterials"},{"key":"991_CR30","doi-asserted-by":"publisher","unstructured":"Herdiana Y, et al. Cytotoxicity enhancement of \u03b1-mangostin with folate-conjugated chitosan nanoparticles in MCF-7 breast cancer cells. Molecules. 2023;28. https:\/\/doi.org\/10.3390\/molecules28227585.","DOI":"10.3390\/molecules28227585"},{"issue":"6","key":"991_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","volume":"11","author":"N Hoshyar","year":"2016","unstructured":"Hoshyar N, et al. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673\u201392.","journal-title":"Nanomedicine"},{"issue":"8","key":"991_CR32","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1080\/21691401.2016.1260578","volume":"45","author":"F Wang","year":"2017","unstructured":"Wang F, et al. Development and characterization of folic acid-conjugated Chitosan nanoparticles for targeted and controlled delivery of Gemcitabinein lung cancer therapeutics. Artif Cells Nanomed Biotechnol. 2017;45(8):1530\u20138.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"991_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12943-024-02163-z","volume":"23","author":"P Kesharwani","year":"2024","unstructured":"Kesharwani P, et al. Folate-engineered Chitosan nanoparticles: next-generation anticancer nanocarriers. Mol Cancer. 2024;23(1):244.","journal-title":"Mol Cancer"},{"issue":"3","key":"991_CR34","first-page":"203","volume":"10","author":"I Nallamuthu","year":"2015","unstructured":"Nallamuthu I, Devi A, Khanum F. Chlorogenic acid loaded Chitosan nanoparticles with sustained release property, retained antioxidant activity and enhanced bioavailability. Asian J Pharm Sci. 2015;10(3):203\u201311.","journal-title":"Asian J Pharm Sci"},{"key":"991_CR35","doi-asserted-by":"publisher","unstructured":"Quester K, et al. Chitosan nanoparticles containing lipoic acid with antioxidant properties as a potential nutritional supplement. Animals. 2022;12. https:\/\/doi.org\/10.3390\/ani12040417.","DOI":"10.3390\/ani12040417"},{"issue":"6","key":"991_CR36","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00289-011-0674-x","volume":"68","author":"J Ji","year":"2012","unstructured":"Ji J, et al. Preparation, characterization, and in vitro release of folic acid-conjugated Chitosan nanoparticles loaded with methotrexate for targeted delivery. Polym Bull. 2012;68(6):1707\u201320.","journal-title":"Polym Bull"},{"key":"991_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2298\/HEMIND141119010V","volume":"70","author":"BB Vidovi\u0107","year":"2015","unstructured":"Vidovi\u0107 BB, et al. Encapsulation of \u03b1-lipoic acid Intochitosan and alginate\/gelatin hydrogel microparticles and its in vitro antioxidant activity. Hemijska Industrija. 2015;70:49\u201358.","journal-title":"Hemijska Industrija"},{"key":"991_CR38","doi-asserted-by":"publisher","unstructured":"Canbolat F, et al. Chitosan nanoparticles loaded with Quercetin and valproic acid: a novel approach for enhancing antioxidant activity against oxidative stress in the SH-SY5Y human neuroblastoma cell line. Biomedicines. 2024;12. https:\/\/doi.org\/10.3390\/biomedicines12020287.","DOI":"10.3390\/biomedicines12020287"},{"issue":"2","key":"991_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa JM, Lobo. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"991_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335.","journal-title":"Int J Pharm"},{"key":"991_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.powtec.2019.10.022","volume":"359","author":"NB Ghomrasni","year":"2020","unstructured":"Ghomrasni NB, et al. Challenges in sample Preparation for measuring nanoparticles size by scanning electron microscopy from suspensions, powder form and complex media. Powder Technol. 2020;359:226\u201337.","journal-title":"Powder Technol"},{"key":"991_CR42","doi-asserted-by":"publisher","first-page":"118650","DOI":"10.1016\/j.fuel.2020.118650","volume":"280","author":"Z Liu","year":"2020","unstructured":"Liu Z, et al. Understanding the stability mechanism of silica nanoparticles: the effect of cations and EOR chemicals. Fuel. 2020;280:118650.","journal-title":"Fuel"},{"key":"991_CR43","doi-asserted-by":"crossref","unstructured":"AlKandari FM et al. Protective effects of propolis and chitosan nanoparticles against ibuprofen-induced hepatotoxicity in albino rats. Diseases, 2024. 12(3).","DOI":"10.3390\/diseases12030049"},{"issue":"1","key":"991_CR44","doi-asserted-by":"publisher","first-page":"21009","DOI":"10.1038\/s41598-024-70794-9","volume":"14","author":"GM Eldeeb","year":"2024","unstructured":"Eldeeb GM, et al. The protective effects of Chitosan and Curcumin nanoparticles against the hydroxyapatite nanoparticles-induced neurotoxicity in rats. Sci Rep. 2024;14(1):21009.","journal-title":"Sci Rep"},{"issue":"1","key":"991_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-009-0284-1","volume":"337","author":"F Khodagholi","year":"2010","unstructured":"Khodagholi F, et al. Retracted article: Chitosan prevents oxidative stress-induced amyloid \u03b2 formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF-\u03baB. Mol Cell Biochem. 2010;337(1):39\u201351.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"991_CR46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1039\/c9tx00221a","volume":"8","author":"IF Mosa","year":"2019","unstructured":"Mosa IF, et al. Synergistic antioxidant capacity of CsNPs and curnps against cytotoxicity, genotoxicity and pro-inflammatory mediators induced by hydroxyapatite nanoparticles in male rats. Toxicol Res. 2019;8(6):939\u201352.","journal-title":"Toxicol Res"},{"issue":"11","key":"991_CR47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/md15110322","volume":"15","author":"Q-Q Ouyang","year":"2017","unstructured":"Ouyang Q-Q, et al. Application of chitosan, chitooligosaccharide, and their derivatives in the treatment of alzheimer\u2019s disease. Mar Drugs. 2017;15(11):322.","journal-title":"Mar Drugs"},{"key":"991_CR48","doi-asserted-by":"publisher","first-page":"113805","DOI":"10.1016\/j.fct.2023.113805","volume":"177","author":"EJ Calabrese","year":"2023","unstructured":"Calabrese EJ, et al. Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms. Food Chem Toxicol. 2023;177:113805.","journal-title":"Food Chem Toxicol"},{"key":"991_CR49","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.tice.2024.102509","volume":"90","author":"SS Hosseini","year":"2024","unstructured":"Hosseini SS, et al. Protective effects of alpha-lipoic acid and alagebrium chloride against testicular dysfunction induced by varicocele and advanced glycation end (AGE)\u2013Rich diet in a rat mode. Tissue Cell. 2024;90:102509.","journal-title":"Tissue Cell"},{"key":"991_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2012.12.041","volume":"1499","author":"Y Koriyama","year":"2013","unstructured":"Koriyama Y, et al. Protective effect of lipoic acid against oxidative stress is mediated by Keap1\/Nrf2-dependent Heme oxygenase-1 induction in the RGC-5 cellline. Brain Res. 2013;1499:145\u201357.","journal-title":"Brain Res"},{"issue":"1","key":"991_CR51","first-page":"590363","volume":"2013","author":"Y-C Lin","year":"2013","unstructured":"Lin Y-C, Lai Y-S, Chou T-C. The protective effect of alpha-lipoic acid in lipopolysaccharide\u2010induced acute lung injury is mediated by Heme oxygenase\u20101. Evidence\u2010Based Complement Altern Med. 2013;2013(1):590363.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"issue":"3","key":"991_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/nano12030502","volume":"12","author":"D Siva","year":"2022","unstructured":"Siva D, et al. Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated Chitosan nanoparticles with supplementation of propionic acid. Nanomaterials. 2022;12(3):502.","journal-title":"Nanomaterials"},{"key":"991_CR53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijbiomac.2014.12.016","volume":"74","author":"S Tripathy","year":"2015","unstructured":"Tripathy S, et al. Chitosan conjugated chloroquine: proficient to protect the induction of liver apoptosis during malaria. Int J Biol Macromol. 2015;74:585\u2013600.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"991_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau K, Kotzur R, Richter F. Blood-brain barrier alterations and their impact on parkinson\u2019s disease pathogenesis and therapy. Transl Neurodegener. 2024;13(1):37.","journal-title":"Transl Neurodegener"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00991-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:03:33Z","timestamp":1770127413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12868-025-00991-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00991-3","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}